Skip to main content

Role of homocysteine & MTHFR C677T gene polymorphism as risk factors for coronary artery disease in young Indians.

Publication ,  Journal Article
Gupta, SK; Kotwal, J; Kotwal, A; Dhall, A; Garg, S
Published in: The Indian journal of medical research
April 2012

Hyperhomocysteinaemia (HCA) either due to mutation of MTHFR gene or deficiency of vitamin B 12 and folic acid, has been reported as a risk factor for coronary artery disease (CAD). The present study was aimed to determine plasma homocysteine (Hcy) levels and to evaluate MTHFR C677T gene polymorphism as risk factors for CAD, and to study the role of Hcy in conjunction with a few other risk factors of CAD in young Indians. The effect of vitamin B12 and folic acid supplements on the raised plasma Hcy levels in patients of CAD was also assessed.The present study included 199 consecutive angiography confirmed CAD patients, <45 yr of age, without any other known pro- coagulant state and 200 age- and sex-matched healthy controls. Fasting blood samples were collected in EDTA and plasma Hcy was estimated by ELISA test and the MTHFR C677T polymorphism detection was carried out by PCR-RFLP method.Significant difference (P<0.001) was found between mean fasting levels of plasma Hcy in cases (22.14 ± 10.62 μmol/l) and controls (17.38 ± 8.46 μmol/l) with an Odds ratio as 1.93 (95% CI, 1.27-2.94). Levels of cholesterol, LDL, and triglycerides were significantly (P<0.001) higher in cases compared with controls.Our study showed significant correlation between hyperhomocysteinaemia and coronary artery disease. Multivariate analysis by logistic regression of the various risk factors of CAD, found high levels of Hcy, cholesterol, LDL and low levels of HDL and smoking as independent predictors of CAD when all other factors were controlled. Significant post-treatment decrease found in HCA was easily modifiable by vitamin intervention irrespective to their CT or TT genotype of C677T MTHFR gene. Further studies to look at the plasma levels of folate and cobalamines and their association with Hcy are required to be done.

Duke Scholars

Published In

The Indian journal of medical research

ISSN

0971-5916

Publication Date

April 2012

Volume

135

Issue

4

Start / End Page

506 / 512

Related Subject Headings

  • Vitamin B 12
  • Triglycerides
  • Smoking
  • Risk Factors
  • Polymorphism, Genetic
  • Middle Aged
  • Microbiology
  • Methylenetetrahydrofolate Reductase (NADPH2)
  • Male
  • Lipoproteins, LDL
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gupta, S. K., Kotwal, J., Kotwal, A., Dhall, A., & Garg, S. (2012). Role of homocysteine & MTHFR C677T gene polymorphism as risk factors for coronary artery disease in young Indians. The Indian Journal of Medical Research, 135(4), 506–512.
Gupta, Santosh Kumar, Jyoti Kotwal, Atul Kotwal, Anil Dhall, and Salil Garg. “Role of homocysteine & MTHFR C677T gene polymorphism as risk factors for coronary artery disease in young Indians.The Indian Journal of Medical Research 135, no. 4 (April 2012): 506–12.
Gupta SK, Kotwal J, Kotwal A, Dhall A, Garg S. Role of homocysteine & MTHFR C677T gene polymorphism as risk factors for coronary artery disease in young Indians. The Indian journal of medical research. 2012 Apr;135(4):506–12.
Gupta, Santosh Kumar, et al. “Role of homocysteine & MTHFR C677T gene polymorphism as risk factors for coronary artery disease in young Indians.The Indian Journal of Medical Research, vol. 135, no. 4, Apr. 2012, pp. 506–12.
Gupta SK, Kotwal J, Kotwal A, Dhall A, Garg S. Role of homocysteine & MTHFR C677T gene polymorphism as risk factors for coronary artery disease in young Indians. The Indian journal of medical research. 2012 Apr;135(4):506–512.

Published In

The Indian journal of medical research

ISSN

0971-5916

Publication Date

April 2012

Volume

135

Issue

4

Start / End Page

506 / 512

Related Subject Headings

  • Vitamin B 12
  • Triglycerides
  • Smoking
  • Risk Factors
  • Polymorphism, Genetic
  • Middle Aged
  • Microbiology
  • Methylenetetrahydrofolate Reductase (NADPH2)
  • Male
  • Lipoproteins, LDL